Politics
Stocks
Business
Investing

Politics
Stocks
Business
Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024

December 20, 2024

RAD 202 receives approval to start Phase 1 therapeutic trial

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

previous post

Westgold Shares Scoping Study for Expansion of Fortnum Gold Operation

next post

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Related Posts

Questcorp Mining Provides Clarification on Private Placement Investment

November 10, 2025

Peter Grandich: Copper, Uranium in “Perfect Storm,” My...

July 29, 2025

SAGA Metals Begins Mobilization Efforts for Maiden Drill...

January 7, 2025

Crypto Market Recap: Bitcoin Hits New All-time High...

July 14, 2025

Walker Lane Resources Ltd. Completes an Updated Mineral...

January 21, 2026

LaFleur Minerals Updates PEA and Beacon Gold Mill...

January 27, 2026

Is Now a Good Time to Invest in...

February 5, 2025

Kobo Resources Extends Gold Mineralisation at Depth and...

February 9, 2026

Alvopetro Announces Q3 2025 Financial Results and an...

November 6, 2025

Manindi Ti-V-Fe Discovery Delivers High-Grade Concentrates

May 16, 2025

Search

Recent Posts

171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns
FDA launches new AI-powered system to track drug and vaccine side effects nationwide
Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate
DAVID MARCUS: Sen Thune has no idea how mad the GOP base is at him
Trump touts 5-0 sweep by endorsed candidates in Tuesday primary elections

Recent Comments

No comments to show.

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

171 million travelers face airport delays as Democrats’ DHS shutdown hits TSA staffing, Scalise warns
March 12, 2026
FDA launches new AI-powered system to track drug and vaccine side effects nationwide
March 12, 2026
Cornyn reverses on filibuster stance to push Trump’s SAVE Act in Senate
March 12, 2026
DAVID MARCUS: Sen Thune has no idea how mad the GOP base is at him
March 12, 2026
Trump touts 5-0 sweep by endorsed candidates in Tuesday primary elections
March 12, 2026
US destroys 16 Iranian mine boats as Strait of Hormuz oil showdown escalates
March 12, 2026

Editors’ Picks

1

Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test
September 19, 2025
2

Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know
December 12, 2024
3

Ad revenue should stabilize for media companies in 2025 — if they have sports
December 31, 2024
4

Trump leaves China guessing what his next move is with unusual inauguration invitation
December 15, 2024
5

Zinc Stocks: 4 Biggest Canadian Companies in 2025
January 15, 2025
6

Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025
December 19, 2024
7

Lead Price Forecast: Top Trends for Lead in 2025
January 11, 2025

banner

Categories

Business (630)
Investing (3,251)
Politics (3,955)
Stocks (1,072)

About us
Contacts
Privacy Policy
Terms and Conditions
Email Whitelisting

Copyright © 2026 bullhedging.com | All Rights Reserved